NovoCure Limited Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 174.1M | 174.3M | 167.2M | 158.8M | 155.0M | 161.3M | 155.1M | 150.4M |
| Cost of Goods Sold | 38.9M | 42.2M | 44.7M | 41.5M | 38.5M | 33.5M | 35.4M | 34.7M |
| Gross Profit | 135.1M | 132.2M | 122.5M | 117.3M | 116.5M | 127.8M | 119.7M | 115.7M |
| R&D Expenses | 58.3M | 60.9M | 54.0M | 55.8M | 53.8M | 51.2M | 51.9M | 55.0M |
| Operating Expenses | 202.5M | 172.6M | 158.5M | 156.9M | 154.3M | 191.1M | 151.8M | 149.3M |
| Operating Income | -67.4M | -40.4M | -36.0M | -39.5M | -37.9M | -63.3M | -32.1M | -33.6M |
| Other Income / Gains | -1.8M | -561K | 6.0M | 4.5M | 7.6M | 8.1M | 10.5M | 10.9M |
| Net Income | -71.1M | -24.5M | -37.3M | -40.1M | -34.3M | -65.9M | -30.6M | -33.4M |
| EPS (Diluted) | -0.62 | -0.22 | -0.33 | -0.36 | -0.31 | -0.61 | -0.28 | -0.31 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.776 | 0.758 | 0.732 | 0.739 | 0.751 | 0.792 | 0.772 | 0.77 |
| General And Administrative Expenses | 0 | 43.0M | 45.9M | 44.0M | 44.8M | 72.5M | 40.1M | 37.7M |
| Selling And Marketing Expenses | 0 | 68.7M | 58.5M | 57.1M | 55.8M | 67.4M | 59.8M | 56.6M |
| Selling General And Administrative Expenses | 144.2M | 111.7M | 104.5M | 101.0M | 100.6M | 139.9M | 99.9M | 94.4M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 241.5M | 214.7M | 203.2M | 198.3M | 192.9M | 224.6M | 187.2M | 184.0M |
| Interest Income | 0 | 0 | 6.0M | 4.5M | 7.6M | 8.1M | 10.5M | 10.9M |
| Interest Expense | 1.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 4.1M | 6.8M | 3.7M | 3.4M | 3.3M | 3.1M | 2.5M | 2.9M |
| Ebitda | -63.3M | -34.2M | -26.4M | -36.1M | -34.5M | -10.5M | -29.6M | -30.7M |
| Ebitdaratio | -0.364 | -0.196 | -0.158 | -0.227 | -0.223 | -0.065 | -0.191 | -0.205 |
| Operating Income Ratio | -0.387 | -0.232 | -0.215 | -0.249 | -0.244 | -0.393 | -0.207 | -0.224 |
| Income Before Tax | -69.3M | -41.0M | -30.0M | -35.0M | -30.3M | -55.2M | -21.6M | -22.7M |
| Income Before Tax Ratio | -0.398 | -0.235 | -0.18 | -0.22 | -0.195 | -0.342 | -0.139 | -0.151 |
| Income Tax Expense | 1.9M | -16.5M | 7.2M | 5.2M | 4.0M | 10.7M | 9.0M | 10.6M |
| Net Income Ratio | -0.409 | -0.141 | -0.223 | -0.253 | -0.221 | -0.409 | -0.197 | -0.222 |
| Epsdiluted | -0.62 | -0.22 | -0.33 | -0.36 | -0.31 | -0.61 | -0.28 | -0.31 |
| Weighted Average Shs Out | 114.1M | 111.5M | 111.9M | 111.6M | 110.3M | 107.8M | 108.2M | 107.7M |
| Weighted Average Shs Out Dil | 114.1M | 111.5M | 111.9M | 111.6M | 110.3M | 107.8M | 108.2M | 107.7M |